These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy. Ishimura N; Kinoshita Y J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655 [TBL] [Abstract][Full Text] [Related]
27. Minimally symptomatic patients with eosinophilic esophagitis should still be actively treated-CON. Lieberman JA Ann Allergy Asthma Immunol; 2019 Jun; 122(6):574-575. PubMed ID: 31171239 [No Abstract] [Full Text] [Related]
28. Molecular Sensitization Profile According to Proton Pump Inhibitor Response in Patients With Esophageal Eosinophilia. Lluncor M; Pedrosa M; Cancelliere N; Rivero-Paparoni D; Burgos A; Fiandor A; Pagola MJ; Quirce S; Caballero T J Investig Allergol Clin Immunol; 2018 Oct; 28(5):354-358. PubMed ID: 30350796 [No Abstract] [Full Text] [Related]
30. Implementation of guidelines in eosinophilic esophagitis at an academic pediatric practice. Harris BR; Hon E; Gupta SK Dis Esophagus; 2018 Aug; 31(8):. PubMed ID: 29757350 [TBL] [Abstract][Full Text] [Related]
31. Pediatric eosinophilic esophagitis: updates for the primary care setting. Ruffner MA; Spergel JM Curr Opin Pediatr; 2018 Dec; 30(6):829-836. PubMed ID: 30239371 [TBL] [Abstract][Full Text] [Related]
32. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients. Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416 [TBL] [Abstract][Full Text] [Related]
34. Commentary: the proton pump inhibitor test - does it have a role in eosinophilic oesophagitis? Fass R; Maradey-Romero C Aliment Pharmacol Ther; 2014 Apr; 39(8):896-7. PubMed ID: 24635313 [No Abstract] [Full Text] [Related]
36. Eosinophilic esophagitis-Where are we today? Ferreira CT; Vieira MC; Furuta GT; Barros FCLF; Chehade M J Pediatr (Rio J); 2019; 95(3):275-281. PubMed ID: 30075121 [TBL] [Abstract][Full Text] [Related]
37. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis. Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856 [TBL] [Abstract][Full Text] [Related]
38. Commentary: the proton pump inhibitor test - does it have a role in eosinophilic oesophagitis? Authors' reply. Moawad FJ; Schoepfer AM Aliment Pharmacol Ther; 2014 Apr; 39(8):897-8. PubMed ID: 24635314 [No Abstract] [Full Text] [Related]
39. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis. Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578 [TBL] [Abstract][Full Text] [Related]
40. Conservative long-term treatment of children with eosinophilic esophagitis. Levine J; Lai J; Edelman M; Schuval SJ Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]